| Primary |
| Product Used For Unknown Indication |
59.6% |
| Non-small Cell Lung Cancer |
10.9% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
6.9% |
| Lung Neoplasm Malignant |
4.2% |
| Pancreatic Carcinoma |
4.0% |
| Hepatic Neoplasm Malignant |
2.5% |
| Adenocarcinoma Pancreas |
2.3% |
| Lung Adenocarcinoma |
2.0% |
| Pancreatic Carcinoma Metastatic |
1.2% |
| Hypertension |
1.0% |
| Pain |
0.9% |
| Nausea |
0.8% |
| Non-small Cell Lung Cancer Metastatic |
0.7% |
| Vomiting |
0.5% |
| Diabetes Mellitus |
0.5% |
| Diarrhoea |
0.5% |
| Constipation |
0.5% |
| Rash |
0.4% |
| Colorectal Cancer Metastatic |
0.4% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
0.4% |
|
| Death |
44.7% |
| Neoplasm Malignant |
7.3% |
| Rash |
5.3% |
| Diarrhoea |
4.8% |
| Incorrect Dose Administered |
4.7% |
| Pneumonia |
3.5% |
| Hospitalisation |
3.1% |
| Vomiting |
3.0% |
| Anaemia |
2.7% |
| Pulmonary Embolism |
2.7% |
| Dyspnoea |
2.4% |
| Disease Progression |
2.1% |
| Off Label Use |
2.1% |
| Pleural Effusion |
1.8% |
| Nausea |
1.7% |
| Respiratory Failure |
1.7% |
| Non-small Cell Lung Cancer |
1.6% |
| Fatigue |
1.6% |
| Pyrexia |
1.6% |
| Thrombocytopenia |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
37.3% |
| Hepatic Neoplasm Malignant |
9.6% |
| Non-small Cell Lung Cancer |
7.7% |
| Ascites |
5.2% |
| Hypertension |
3.9% |
| Diarrhoea |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Muscle Spasms |
3.2% |
| Enteritis |
3.1% |
| Diabetes Mellitus |
2.9% |
| Prophylaxis |
2.7% |
| Pancreatic Carcinoma |
2.4% |
| Insomnia |
2.3% |
| Nausea |
2.1% |
| Pain |
1.9% |
| Lung Neoplasm Malignant |
1.8% |
| Vomiting |
1.7% |
| Unevaluable Event |
1.6% |
| Anxiety Disorder |
1.6% |
| Adenocarcinoma Pancreas |
1.5% |
|
| Diarrhoea |
10.4% |
| Death |
9.4% |
| Oedema Peripheral |
7.6% |
| Rash |
7.6% |
| Dyspnoea |
7.0% |
| Anaemia |
6.3% |
| Off Label Use |
5.3% |
| Vomiting |
5.1% |
| Epistaxis |
4.7% |
| General Physical Health Deterioration |
4.5% |
| Haemorrhagic Anaemia |
3.7% |
| Hyperkalaemia |
3.7% |
| Interstitial Lung Disease |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Pneumonia |
3.5% |
| Dehydration |
2.9% |
| Pyrexia |
2.9% |
| Urinary Tract Infection |
2.9% |
| Ascites |
2.7% |
| Neoplasm Malignant |
2.7% |
|
| Concomitant |
| Pancreatic Carcinoma |
12.2% |
| Non-small Cell Lung Cancer |
11.5% |
| Breast Cancer Metastatic |
9.4% |
| Drug Use For Unknown Indication |
8.6% |
| Pancreatic Carcinoma Metastatic |
7.9% |
| Adenocarcinoma Pancreas |
7.6% |
| Lung Neoplasm Malignant |
7.6% |
| Pain |
7.6% |
| Product Used For Unknown Indication |
5.8% |
| Lung Adenocarcinoma |
4.7% |
| Hepatic Neoplasm Malignant |
2.2% |
| Hypertension |
2.2% |
| Cardiomyopathy |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Metastatic Renal Cell Carcinoma |
1.8% |
| Nausea |
1.8% |
| Constipation |
1.4% |
| Deep Vein Thrombosis |
1.4% |
| Glioma |
1.4% |
| Pancreatic Carcinoma Non-resectable |
1.4% |
|
| Renal Failure |
14.3% |
| Gastrointestinal Toxicity |
12.7% |
| Death |
7.9% |
| Neoplasm Progression |
6.3% |
| Thrombosis |
6.3% |
| Dehydration |
4.8% |
| Interstitial Lung Disease |
4.8% |
| Rash |
4.8% |
| Recurrent Cancer |
4.8% |
| Vomiting |
4.8% |
| Weight Bearing Difficulty |
4.8% |
| Drug Dose Omission |
3.2% |
| Hepatic Neoplasm Malignant |
3.2% |
| Osteonecrosis Of Jaw |
3.2% |
| Rectal Haemorrhage |
3.2% |
| Small Intestinal Haemorrhage |
3.2% |
| Toothache |
3.2% |
| Acute Respiratory Failure |
1.6% |
| Arthritis |
1.6% |
| Aspartate Aminotransferase Increased |
1.6% |
|
| Interacting |
| Product Used For Unknown Indication |
52.4% |
| Lung Neoplasm Malignant |
13.3% |
| Cancer Pain |
7.8% |
| Pain |
6.6% |
| Bronchopneumonia |
4.8% |
| Chemotherapy |
2.4% |
| Dyslipidaemia |
2.4% |
| Lung Adenocarcinoma |
2.4% |
| Non-small Cell Lung Cancer Stage Iiib |
1.8% |
| Premedication |
1.8% |
| Diarrhoea |
1.2% |
| Non-small Cell Lung Cancer |
1.2% |
| Antibiotic Therapy |
0.6% |
| Embolism Venous |
0.6% |
| Radiotherapy |
0.6% |
|
| Drug Interaction |
31.6% |
| Rash |
31.6% |
| Drug Level Decreased |
13.2% |
| Somnolence |
7.9% |
| Swelling |
5.3% |
| Cardiac Failure |
2.6% |
| Contusion |
2.6% |
| Death |
2.6% |
| Interstitial Lung Disease |
2.6% |
|
